Molecular mechanisms of the polymerization of fibrin and the formation of its three-dimensional network

The results of biochemical, immunochemical, and X-ray studies of the structures of fibrinogen and fibrin molecules were analyzed. The mechanisms of the successive formation of the fibrin three-dimensional network were described: the polymerization of monomeric molecules with the formation of bifilar protofibrils, the lateral association of protofibrils, and the embranchment of the forming fibrils. Data on the electron and confocal microscopy of the polymeric fibrin were considered. The role of the known polymerization centers of fibrin which participated in the formation of protofibrils and their lateral association was discussed. Data on the existence of the previously unknown polymerization centers were given. In particular, the experimental results demonstrated that one of such centers which participated in the formation of protofibrils was located in the Bβ12–46 fragment, and did not require the cleavage of fibrinopeptide B for its functioning. The results of the computer modeling of the spatial structure of the fibrin(ogen) molecule and the intermolecular interactions in the course of the fibrin polymerization were presented. The location of the αC domains in the fibrin(ogen) molecule and their role in the polymerization process were discussed. Information on the structure of the calciumbinding sites of fibrin(ogen) and the functional role of Ca2+ in fibrin polymerization was published. The structure of factor XIII(a) and the mechanisms of fibrin stabilization by this factor were briefly described.

[1]  Y. Matsuka,et al.  Cross-Linking of Fibronectin to C-Terminal Fragments of the Fibrinogen α-Chain by Factor XIIIa , 1997, Journal of protein chemistry.

[2]  J. Weisel,et al.  The elasticity of an individual fibrin fiber in a clot. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Weisel,et al.  The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. , 1993, Journal of molecular biology.

[4]  W. Brandt,et al.  Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the gamma-chain. Sequence of carboxy-terminal cyanogen bromide gamma-chain fragments. , 1987, Biochemistry.

[5]  L. Lorand,et al.  The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Nieuwenhuizen,et al.  Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites. , 2000, Biochemistry.

[7]  K. Siebenlist,et al.  Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Doolittle,et al.  Amino-Acid Sequence Investigations of Fibrinopeptides from Various Mammals: Evolutionary Implications , 1964, Nature.

[9]  W. Delano.  The PyMOL Molecular Graphics System (2002) , 2002 .

[10]  R. Kini,et al.  Prediction of potential protein‐protein interaction sites from amino acid sequence , 1996, FEBS letters.

[11]  J. Weisel,et al.  Dynamic imaging of fibrin network formation correlated with other measures of polymerization. , 2007, Blood.

[12]  G. Grieninger.  Contribution of the αEC Domain to the Structure and Function of Fibrinogen‐420 , 2001 .

[13]  L. Lorand,et al.  Structural origins of fibrin clot rheology. , 1999, Biophysical journal.

[14]  K. Siebenlist,et al.  Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. , 1996, Biochemistry.

[15]  R. Doolittle,et al.  Amino acid sequence of the beta chain of human fibrinogen. , 1979, Biochemistry.

[16]  L. Lorand,et al.  Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen. , 1983, The Journal of clinical investigation.

[17]  R. Doolittle,et al.  The arrangement of disulfide bonds in fragment D from human fibrinogen. , 1978, Thrombosis research.

[18]  J. Weisel,et al.  Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization. , 1993, The Journal of biological chemistry.

[19]  N. Tjandra,et al.  NMR Solution Structure, Stability, and Interaction of the Recombinant Bovine Fibrinogen alphaC-Domain Fragment , 2007 .

[20]  B. Kudryk,et al.  Fibrinogen Biosynthesis , 2001, Thrombosis and Haemostasis.

[21]  E. Hewat,et al.  Electron microscope structural study of modified fibrin and a related modified fibrinogen aggregate. , 1983, Journal of molecular biology.

[22]  W. Nieuwenhuizen,et al.  Evidence for the localization of a calcium-binding site in the amino-terminal disulphide knot of fibrin (ogen). , 1983, Thrombosis research.

[23]  P. Wiltzius,et al.  Fibrin polymerization studied by static and dynamic light‐scattering as a function of fibrinopeptide A release , 1982, Biopolymers.

[24]  M. Borggrefe,et al.  Changes in fibrinogen and fibrin induced by a peptide analog of fibrinogen γ365–380 , 2007, Journal of thrombosis and haemostasis : JTH.

[25]  P. G. Gritsenko,et al.  A neoantigenic determinant in coiled coil region of human fibrin beta-chain. , 2009, Thrombosis research.

[26]  S. Lord,et al.  Polymerization Site a Function Dependence on Structural Integrity of Its Nearby Calcium Binding Site , 2001, Annals of the New York Academy of Sciences.

[27]  J. Weisel.  Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. , 1986, Biophysical journal.

[28]  J. Hermans,et al.  Size and density of fibrin fibers from turbidity. , 1978, Macromolecules.

[29]  R. Laine,et al.  Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides. , 1982, The Journal of biological chemistry.

[30]  C. Fenselau,et al.  Determination of the sialylation pattern of human fibrinogen glycopeptides with fast atom bombardment. , 1984, Biochemistry.

[31]  A. Laudano,et al.  Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Blombäck,et al.  Disulfide bridges in nh2 -terminal part of human fibrinogen. , 1976, Thrombosis research.

[33]  W. Nieuwenhuizen,et al.  Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products. , 1981, Thrombosis research.

[34]  J. Weisel,et al.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. , 2005, Blood.

[35]  M. Matsuda,et al.  Hereditary Disorders of Fibrinogen , 2001, Annals of the New York Academy of Sciences.

[36]  E. Mihályi.  Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B. , 1988, Biochemistry.

[37]  S. Pizzo,et al.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. , 1973, The Journal of biological chemistry.

[38]  L. Betts,et al.  The structure of fibrinogen fragment D with the ‘A’ knob peptide GPRVVE , 2006, Journal of thrombosis and haemostasis : JTH.

[39]  J. Weisel,et al.  Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. , 2007, Biochemistry.

[40]  Klaus Schulten,et al.  Molecular basis of fibrin clot elasticity. , 2008, Structure.

[41]  W. Nieuwenhuizen,et al.  Molecular mechanisms of initiation of fibrinolysis by fibrin , 2003, Thrombosis and Haemostasis.

[42]  M. Mosesson.  The fibrin cross‐linking debate: cross‐linked γ‐chains in fibrin fibrils bridge ‘transversely’ between strands: yes , 2004, Journal of thrombosis and haemostasis : JTH.

[43]  J. Weisel,et al.  Recombinant BβArg14His fibrinogen implies participation of N-terminus of Bβ chain in desA fibrin polymerization , 2003 .

[44]  R. Superfine,et al.  Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3. , 2004, Biophysical journal.

[45]  S. Lord,et al.  The Formation of β Fibrin Requires a Functional a Site , 2001 .

[46]  H. Ris,et al.  Electron microscopy of fine fibrin clots and fine and coarse fibrin films. Observations of fibers in cross-section and in deformed states. , 1984, Journal of molecular biology.

[47]  J. Finlayson,et al.  Human fibrinogen heterogeneities. 3. Identification of chain variants. , 1972, The Journal of biological chemistry.

[48]  P. Janmey,et al.  Kinetics of formation of fibrin oligomers. II. Size distributions of ligated oligomers , 1982, Biopolymers.

[49]  Y. Fu,et al.  Fib420: a normal human variant of fibrinogen with two extended alpha chains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Gawinowicz,et al.  Identification of the α Chain Lysine Donor Sites Involved in Factor XIIIa Fibrin Cross-linking* , 1996, The Journal of Biological Chemistry.

[51]  D. Farrell,et al.  Resistance of γA/γ′ Fibrin Clots to Fibrinolysis* , 1997, The Journal of Biological Chemistry.

[52]  N. Bark,et al.  Fibrinopeptides and fibrin gel structure. , 2004, Biophysical chemistry.

[53]  G. Smejkal,et al.  Isolation and Characterization of the Fibrin Intermediate Arising from Cleavage of One Fibrinopeptide A from Fibrinogen* , 1996, The Journal of Biological Chemistry.

[54]  R. Williams.  Band patterns seen by electron microscopy in ordered arrays of bovine and human fibrinogen and fibrin after negative staining. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Doolittle,et al.  Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. , 2006, Biochemistry.

[56]  E. Davie,et al.  Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen , 1997 .

[57]  W. Nieuwenhuizen,et al.  Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization. , 2004, Thrombosis research.

[58]  J. Weisel,et al.  The Structure and Function of the αC Domains of Fibrinogen , 2001 .

[59]  L. Westrick,et al.  Incorporation of thrombospondin into fibrin clots. , 1985, The Journal of biological chemistry.

[60]  J. Mimuro,et al.  Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bβ Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bβ Asn-158 , 1999 .

[61]  J. Weisel,et al.  The Ultrastructure of Fibrinogen Caracas II Molecules, Fibers, and Clots (*) , 1996, The Journal of Biological Chemistry.

[62]  L. Lorand.  Factor XIII: Structure, Activation, and Interactions with Fibrinogen and Fibrin , 2001, Annals of the New York Academy of Sciences.

[63]  M. Mosesson,et al.  Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). , 1981, Biochemistry.

[64]  B. Blombäck.  Fibrinogen and fibrin--proteins with complex roles in hemostasis and thrombosis. , 1996, Thrombosis research.

[65]  S. Lord,et al.  Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation. , 2002, Biochemistry.

[66]  J. Weisel.  Cross‐linked γ‐chains in a fibrin fibril are situated transversely between its strands , 2004, Journal of thrombosis and haemostasis : JTH.

[67]  L. Medved,et al.  Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen. , 1996, Biochemistry.

[68]  K. Siebenlist,et al.  The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin. , 1990, The Journal of biological chemistry.

[69]  R. Doolittle,et al.  Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. , 1999, Biochemistry.

[70]  G. Gilliland,et al.  Crystal structure of the complex between thrombin and the central "E" region of fibrin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Redman,et al.  Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. , 1994, The Journal of biological chemistry.

[72]  Paul,et al.  Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. , 1985, The Journal of biological chemistry.

[73]  R. Doolittle.  X‐ray crystallographic studies on fibrinogen and fibrin , 2003, Journal of thrombosis and haemostasis : JTH.

[74]  G. Tsurupa,et al.  Structural Organization of the Fibrin(ogen) αC-Domain† , 2002 .

[75]  R. Doolittle,et al.  Crystal structure of fragment double-D from human fibrin with two different bound ligands. , 1998, Biochemistry.

[76]  R. Superfine,et al.  A Comparison of the Mechanical and Structural Properties of Fibrin Fibers with Other Protein Fibers , 2007, Cell Biochemistry and Biophysics.

[77]  J. Soria,et al.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[78]  A. Henschen-Edman.  Fibrinogen Non‐Inherited Heterogeneity and Its Relationship to Function in Health and Disease , 2001, Annals of the New York Academy of Sciences.

[79]  J. Weisel,et al.  Role of the alpha C domains of fibrin in clot formation. , 1994, Biochemistry.

[80]  E. Davie,et al.  gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. , 1984, Biochemistry.

[81]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[82]  N. Tjandra,et al.  Identification of an ordered compact structure within the recombinant bovine fibrinogen alphaC-domain fragment by NMR. , 2006, Biochemistry.

[83]  S. Lord,et al.  Insight from Studies with Recombinant Fibrinogens , 2001, Annals of the New York Academy of Sciences.

[84]  Crystal structure of a recombinant αEC domain from human fibrinogen-420 , 1998 .

[85]  J. Soria,et al.  Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots. , 1996, Biophysical journal.

[86]  I. Mochalkin,et al.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[87]  C. Dang,et al.  Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence. , 1985, The Journal of biological chemistry.

[88]  R. Piessens,et al.  Metabolism and Distribution of Fibrinogen. I. FIBRINOGEN TURNOVER IN PHYSIOLOGICAL CONDITIONS IN HUMANS , 1972, British journal of haematology.

[89]  J. Weisel,et al.  Polymerization of fibrin: Direct observation and quantification of individual B:b knob-hole interactions. , 2007, Blood.

[90]  P. G. Gritsenko,et al.  Functional role of Bβ‐chain N‐terminal fragment in the fibrin polymerization process , 2007, The FEBS journal.

[91]  Mosesson Mw.  Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. , 1997 .

[92]  K. Siebenlist,et al.  Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis. , 1994, The Journal of biological chemistry.

[93]  J C Haselgrove,et al.  Three-dimensional reconstruction of fibrin clot networks from stereoscopic intermediate voltage electron microscope images and analysis of branching. , 1995, Biophysical journal.

[94]  P. Pl,et al.  [Structural organization and localization of the C-terminal alpha-chain fragments in the fibrinogen molecule]. , 1981 .

[95]  R. Doolittle,et al.  The amino acid sequence of the α-chain of human fibrinogen , 1979, Nature.

[96]  E. Brown,et al.  Sialic acid. A calcium-binding carbohydrate. , 1977, The Journal of biological chemistry.

[97]  A. Laudano,et al.  Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. , 1980, Biochemistry.

[98]  R. Hill,et al.  Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[99]  J. Weisel,et al.  Twisting of fibrin fibers limits their radial growth. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[100]  Sergiy Yakovlev,et al.  Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. , 2006, Biochemistry.

[101]  J. Weisel,et al.  Do the isolated fibrinogen αC-domains form ordered oligomers? , 2004 .

[102]  J. Hermans,et al.  Fibrin Assembly: A Comparison of Electron Microscopic and Light Scattering Results , 1980, Thrombosis and Haemostasis.

[103]  M. Mosesson.  Fibrinogen and fibrin structure and functions , 2005, Journal of thrombosis and haemostasis : JTH.

[104]  N. Volkmann,et al.  The crystal structure of modified bovine fibrinogen. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[105]  S. Lord,et al.  The impaired polymerization of fibrinogen Longmont (Bbeta166Arg-->Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers. , 2001, Blood.

[106]  N. Kirschbaum,et al.  Characterization of the gamma chain platelet binding site on fibrinogen fragment D. , 1992, Blood.

[107]  A. Budzynski,et al.  The (DD)E complex is maintained by a composite fibrin polymerization site. , 1994, Biochemistry.

[108]  J. Weisel,et al.  Electron microscope investigation of the early stages of fibrin assembly. Twisted protofibrils and fibers. , 1990, Journal of molecular biology.

[109]  Y. Sakata,et al.  Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. , 1980, The Journal of clinical investigation.

[110]  R. Dominguez,et al.  Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-Å resolution , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[111]  R. Doolittle,et al.  Crystal structure of native chicken fibrinogen at 2.7 A resolution. , 2001, Biochemistry.